(CNN) – Pfizer is working to get its COVID-19 combating capsule utilized in extra folks.
Paxlovid is at present approved to deal with COVID-19 in high-risk people 12 and older.
Pfizer is planning to review the drug in youngsters age 6 to 18.
The pharmaceutical big can also be awaiting full approval from the Meals and Drug Administration on the capsule for the teams it’s at present approved to deal with.
The corporate mentioned it expects that call within the second half of the 12 months.
Pfizer’s chief scientific officer mentioned the corporate can also be engaged on a subsequent technology capsule to assist deal with COVID-19.
Copyright 2022 CNN Newsource. All rights reserved.
